Skip to content

BMI at diagnosis of childhood acute lymphoblastic leukemia : effect on induction outcomes

BMI at diagnosis of childhood acute lymphoblastic leukemia : effect on induction outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210216008
Enrollment
196
Registered
2021-02-16
Start date
2021-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric with acute lymphoblastic leukemia Pediatrics Acute lymphoblastic leukemia BMI remission outcomes

Interventions

BMI for age z score is less than minus two,BMI-for-age Z score is between minus two and plus two,Overweight and obesity are BMI-for-age Z score are more than plus two
underweight patient,Normal weight patient,Overweight and obesity patient

Sponsors

Piyathida Wongmast
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed 0-18 yr childhood acute lymphoblastic leukemia patients treated between 2014 and 2019 in 3 tertiary hospitals in Thailand, from Thai pediatric oncology group(TPOG) and treated with TPOG protocol.

Exclusion criteria

Exclusion criteria: At least one of the following; 1. Children younger than 2 years, normative BMI values unavailable 2. Incomplete medical record. 3. Previously other cancer. 4. Dead before induction chemotherapy. 5. Patients treated by individual protocol. 6. Known syndrome (e.g. Down) or Developmental disorder

Design outcomes

Primary

MeasureTime frame
remission rate 4 weeks after start induction bone marrow examination

Secondary

MeasureTime frame
MRD at the end of induction 4 weeks after start induction chemotherapy flow cytometry,mortality outcomes 4 weeks after start induction chemotherapy number and percentage,adverse events during induction chemotherapy number and percentage,duration of induction timing between start induction chemotherapy until finish induction chemotherapy continuous data,time to ANC recovery timing between start induction chemotherapy until ANC recover more than 500 and 1,000 /microL continuous data,time to platelet recovery timing between start induction chemotherapy until platelet recover more than 50,000 and 100,000 /mm3 continuous data

Countries

Thailand

Contacts

Public ContactPiyathida Wongmast

Khon Kaen university

piyathida@kku.ac.th0817178109

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026